Working… Menu
Trial record 56 of 435 for:    colon cancer AND Capecitabine AND colon cancer

Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00296062
Recruitment Status : Terminated (Trial did not move to Phase II portion due to poor tolerance of treatment)
First Posted : February 24, 2006
Last Update Posted : January 16, 2012
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Case Comprehensive Cancer Center

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : October 2009
Actual Study Completion Date : May 2011